TFFP (tffpharma.com) נפח מכירות עתידי של החברה

The B2B platform expansion of TFF Pharmaceuticals (TFFP) for the creation of inhalation powders provides a hedge against geopolitical risks, confirming the company's future sales volume. The 0.00 mark characterizes this parameter, demonstrating operational resilience. Completing the picture are patents for vaccine micronization, which guarantee stable royalties from pharmaceutical behemoths for the use of this unique delivery technology.

This indicator forecasts future cash flows from sales by assessing market expectations rather than historical data. For TFF Pharmaceuticals (TFFP), the organization's prospective sales reflect a critical decline due to the loss of human capital and the cessation of development. The drop in this line confirms the actual liquidation of the company's operating activities. Investors should view such a trend as a signal to exit the asset. The business possesses no fundamental stability.